Analysts Anticipate The Clorox Company (NYSE:CLX) Will Post Earnings of $0.98 Per Share

Brokerages expect The Clorox Company (NYSE:CLXGet Rating) to post $0.98 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Clorox’s earnings. The lowest EPS estimate is $0.89 and the highest is $1.07. Clorox posted earnings of $1.62 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 39.5%. The company is expected to announce its next earnings results after the market closes on Monday, January 1st.

On average, analysts expect that Clorox will report full-year earnings of $4.24 per share for the current financial year, with EPS estimates ranging from $3.96 to $4.35. For the next year, analysts forecast that the company will report earnings of $5.97 per share, with EPS estimates ranging from $4.85 to $6.43. Zacks’ EPS averages are a mean average based on a survey of research analysts that that provide coverage for Clorox.

Clorox (NYSE:CLXGet Rating) last released its quarterly earnings results on Thursday, February 3rd. The company reported $0.66 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.78 by ($0.12). Clorox had a return on equity of 86.36% and a net margin of 3.49%. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the business posted $2.03 earnings per share.

A number of research firms recently commented on CLX. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Clorox from $162.00 to $148.00 and set a “hold” rating on the stock in a research report on Friday, February 4th. Morgan Stanley dropped their price target on shares of Clorox from $154.00 to $140.00 and set an “underweight” rating for the company in a research report on Friday, February 4th. DA Davidson reduced their price target on Clorox from $162.00 to $127.00 and set a “neutral” rating on the stock in a research report on Monday, February 7th. The Goldman Sachs Group lowered their price objective on Clorox from $145.00 to $127.00 in a research note on Tuesday, March 29th. Finally, Barclays cut their target price on Clorox from $132.00 to $117.00 and set an “underweight” rating for the company in a research report on Friday, April 1st. Ten investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Sell” and an average price target of $148.31.

Several large investors have recently modified their holdings of CLX. State Street Corp raised its holdings in Clorox by 4.1% during the 4th quarter. State Street Corp now owns 8,223,034 shares of the company’s stock worth $1,433,768,000 after purchasing an additional 327,488 shares during the last quarter. Geode Capital Management LLC raised its stake in Clorox by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 2,331,231 shares of the company’s stock worth $405,639,000 after buying an additional 54,921 shares during the last quarter. Morgan Stanley lifted its holdings in Clorox by 12.2% in the third quarter. Morgan Stanley now owns 1,994,537 shares of the company’s stock valued at $330,317,000 after buying an additional 216,687 shares during the period. Bank of New York Mellon Corp boosted its position in Clorox by 2.0% during the third quarter. Bank of New York Mellon Corp now owns 1,542,002 shares of the company’s stock valued at $255,369,000 after acquiring an additional 30,655 shares during the last quarter. Finally, Stifel Financial Corp grew its holdings in Clorox by 5.7% during the 4th quarter. Stifel Financial Corp now owns 1,407,022 shares of the company’s stock worth $245,335,000 after acquiring an additional 76,072 shares during the period. Institutional investors own 77.34% of the company’s stock.

Shares of CLX traded down $0.68 during midday trading on Wednesday, reaching $145.77. 3,657 shares of the stock were exchanged, compared to its average volume of 1,551,218. The stock’s 50 day simple moving average is $141.64 and its 200 day simple moving average is $159.45. The company has a market cap of $17.91 billion, a P/E ratio of 73.19, a PEG ratio of 5.76 and a beta of 0.23. Clorox has a twelve month low of $127.02 and a twelve month high of $196.65. The company has a quick ratio of 0.36, a current ratio of 0.67 and a debt-to-equity ratio of 3.84.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 13th. Shareholders of record on Wednesday, April 27th will be given a $1.16 dividend. This represents a $4.64 annualized dividend and a yield of 3.18%. The ex-dividend date of this dividend is Tuesday, April 26th. Clorox’s dividend payout ratio (DPR) is currently 233.17%.

About Clorox (Get Rating)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.

Read More

Get a free copy of the Zacks research report on Clorox (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.